Fortis Healthcare Share Price
Sector: Healthcare Facilities
800.45 +9.55 (1.21%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
786.25
Today’s High
801.05
52 Week Low
452.75
52 Week High
793.35
797.10 +6.40 (0.81%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
786.10
Today’s High
800.95
52 Week Low
453
52 Week High
793
Key Metrics
- Market Cap (In Cr) 60558.79
- Beta 1.06
- Div. Yield (%) 0.13
- P/B 6.69
- TTM P/E 68.07
- Peg Ratio 6.56
- Sector P/E 22.44
- D/E 0
- Open Price 792.05
- Prev Close 790.9
Fortis Healthcare Analysis
Price Analysis
-
1 Week5.69%
-
3 Months17.7%
-
6 Month17.63%
-
YTD9.84%
-
1 Year64.28%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 4
- Buy
- 8
- 8
- 8
- 8
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 12
- 12
- 13
- 13
Fortis Healthcare News
Lupin, Aurobindo among Axis Sec's top pharma & hospital picks post strong Q4
2 min read . 05 Jun 2025IHH Healthcare arm increases damages sought from Daiichi Sankyo to ₹11,800 crore
1 min read . 20 May 2025Best stock recommendations today: MarketSmith India's top picks for 15 May
4 min read . 15 May 2025Fortis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 7782.75
- Selling/ General/ Admin Expenses Total
- 2797.86
- Depreciation/ Amortization
- 385.61
- Other Operating Expenses Total
- 1566.76
- Total Operating Expense
- 6669.76
- Operating Income
- 1112.99
- Net Income Before Taxes
- 1007.04
- Net Income
- 774.21
- Diluted Normalized EPS
- 11.21
- Period
- 2025
- Total Assets
- 13691.53
- Total Liabilities
- 4775.01
- Total Equity
- 8916.52
- Tangible Book Valueper Share Common Eq
- 57.46
- Period
- 2025
- Cashfrom Operating Activities
- 1423.93
- Cashfrom Investing Activities
- -779.38
- Cashfrom Financing Activities
- -713.84
- Net Changein Cash
- -69.75
- Period
- 2024
- Total Revenue
- 6892.92
- Selling/ General/ Admin Expenses Total
- 3764.77
- Depreciation/ Amortization
- 342.5
- Other Operating Expenses Total
- 11.77
- Total Operating Expense
- 5951.4
- Operating Income
- 941.51
- Net Income Before Taxes
- 857.97
- Net Income
- 598.88
- Diluted Normalized EPS
- 7.74
- Period
- 2024
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023
- Total Revenue
- 6297.63
- Selling/ General/ Admin Expenses Total
- 3504.95
- Depreciation/ Amortization
- 315.74
- Other Operating Expenses Total
- 11.43
- Total Operating Expense
- 5438.42
- Operating Income
- 859.22
- Net Income Before Taxes
- 813.68
- Net Income
- 588.73
- Diluted Normalized EPS
- 6.87
- Period
- 2023
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023
- Cashfrom Operating Activities
- 822.23
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022
- Total Revenue
- 5717.61
- Selling/ General/ Admin Expenses Total
- 3063.26
- Depreciation/ Amortization
- 300.84
- Other Operating Expenses Total
- 11.16
- Total Operating Expense
- 4642.55
- Operating Income
- 1075.06
- Net Income Before Taxes
- 987.79
- Net Income
- 555.12
- Diluted Normalized EPS
- 3.98
- Period
- 2022
- Total Assets
- 11884.75
- Total Liabilities
- 5706.51
- Total Equity
- 6178.24
- Tangible Book Valueper Share Common Eq
- 22.69
- Period
- 2022
- Cashfrom Operating Activities
- 879.11
- Cashfrom Investing Activities
- -514.38
- Cashfrom Financing Activities
- -517.31
- Net Changein Cash
- -152.52
- Period
- 2021
- Total Revenue
- 4030.12
- Selling/ General/ Admin Expenses Total
- 2424.81
- Depreciation/ Amortization
- 290.6
- Other Operating Expenses Total
- 24.06
- Total Operating Expense
- 3902.96
- Operating Income
- 127.16
- Net Income Before Taxes
- 43.3
- Net Income
- -109.76
- Diluted Normalized EPS
- -1.48
- Period
- 2021
- Total Assets
- 11154.69
- Total Liabilities
- 5034.88
- Total Equity
- 6119.81
- Tangible Book Valueper Share Common Eq
- 30.92
- Period
- 2021
- Cashfrom Operating Activities
- 485.49
- Cashfrom Investing Activities
- -135.1
- Cashfrom Financing Activities
- -142.93
- Net Changein Cash
- 212.01
- Period
- 2020
- Total Revenue
- 4632.32
- Selling/ General/ Admin Expenses Total
- 2841.78
- Depreciation/ Amortization
- 291.73
- Other Operating Expenses Total
- 13.72
- Total Operating Expense
- 4251.83
- Operating Income
- 380.49
- Net Income Before Taxes
- 239.36
- Net Income
- 57.94
- Diluted Normalized EPS
- 0.24
- Period
- 2020
- Total Assets
- 11347.82
- Total Liabilities
- 4686.73
- Total Equity
- 6661.09
- Tangible Book Valueper Share Common Eq
- 37.94
- Period
- 2020
- Cashfrom Operating Activities
- 171.54
- Cashfrom Investing Activities
- 60.42
- Cashfrom Financing Activities
- -861.61
- Net Changein Cash
- -626.59
- Period
- 2019
- Total Revenue
- 4469.36
- Selling/ General/ Admin Expenses Total
- 3107.42
- Depreciation/ Amortization
- 231.81
- Other Operating Expenses Total
- 7.24
- Total Operating Expense
- 4686.9
- Operating Income
- -217.54
- Net Income Before Taxes
- -110.1
- Net Income
- -298.94
- Diluted Normalized EPS
- -1.84
- Period
- 2019
- Total Assets
- 11951.27
- Total Liabilities
- 5350.47
- Total Equity
- 6600.8
- Tangible Book Valueper Share Common Eq
- 36.95
- Period
- 2019
- Cashfrom Operating Activities
- -87.62
- Cashfrom Investing Activities
- -3322.74
- Cashfrom Financing Activities
- 4256.61
- Net Changein Cash
- 798.76
- Period
- 2025-03-31
- Total Revenue
- 2007.2
- Selling/ General/ Admin Expenses Total
- 701.83
- Depreciation/ Amortization
- 102.23
- Other Operating Expenses Total
- 406.88
- Total Operating Expense
- 1727.53
- Operating Income
- 279.67
- Net Income Before Taxes
- 236.55
- Net Income
- 183.89
- Diluted Normalized EPS
- 3
- Period
- 2025-03-31
- Total Assets
- 13691.53
- Total Liabilities
- 4775.01
- Total Equity
- 8916.52
- Tangible Book Valueper Share Common Eq
- 57.46
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 1423.93
- Cashfrom Investing Activities
- -779.38
- Cashfrom Financing Activities
- -713.84
- Net Changein Cash
- -69.75
- Period
- 2024-12-31
- Total Revenue
- 1928.26
- Selling/ General/ Admin Expenses Total
- 708.01
- Depreciation/ Amortization
- 97.33
- Other Operating Expenses Total
- 391.66
- Total Operating Expense
- 1626.67
- Operating Income
- 301.59
- Net Income Before Taxes
- 279.39
- Net Income
- 247.9
- Diluted Normalized EPS
- 2.99
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1988.39
- Selling/ General/ Admin Expenses Total
- 699.15
- Depreciation/ Amortization
- 95.05
- Other Operating Expenses Total
- 393.57
- Total Operating Expense
- 1708.38
- Operating Income
- 280.01
- Net Income Before Taxes
- 261.05
- Net Income
- 176.46
- Diluted Normalized EPS
- 2.93
- Period
- 2024-09-30
- Total Assets
- 13596.82
- Total Liabilities
- 5749.54
- Total Equity
- 7847.28
- Tangible Book Valueper Share Common Eq
- 43.09
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 531.4
- Cashfrom Investing Activities
- -307.69
- Cashfrom Financing Activities
- -315.41
- Net Changein Cash
- -91.64
- Period
- 2024-06-30
- Total Revenue
- 1858.9
- Selling/ General/ Admin Expenses Total
- 688.87
- Depreciation/ Amortization
- 91
- Other Operating Expenses Total
- 374.65
- Total Operating Expense
- 1607.18
- Operating Income
- 251.72
- Net Income Before Taxes
- 230.05
- Net Income
- 165.96
- Diluted Normalized EPS
- 2.2
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1785.88
- Selling/ General/ Admin Expenses Total
- 641.3
- Depreciation/ Amortization
- 92.23
- Other Operating Expenses Total
- 349.87
- Total Operating Expense
- 1493.94
- Operating Income
- 291.94
- Net Income Before Taxes
- 271.38
- Net Income
- 178.73
- Diluted Normalized EPS
- 2.33
- Period
- 2024-03-31
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023-12-31
- Total Revenue
- 1679.68
- Selling/ General/ Admin Expenses Total
- 644.73
- Depreciation/ Amortization
- 86.91
- Other Operating Expenses Total
- 357.21
- Total Operating Expense
- 1474.91
- Operating Income
- 204.77
- Net Income Before Taxes
- 183.15
- Net Income
- 134.67
- Diluted Normalized EPS
- 1.71
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fortis Healthcare Technical
Moving Average
SMA
- 5 Day756.36
- 10 Day758.6
- 20 Day748.67
- 50 Day706.78
- 100 Day668.63
- 300 Day653.75
Fortis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1271.1
- 4.75
- 0.38
- 1274.4
- 837
- 123569.58
- Apollo Hospitals Enterprise
- 7160
- 58.35
- 0.82
- 7545.1
- 6002.15
- 102849.01
- Fortis Healthcare
- 800.45
- 9.55
- 1.21
- 793.35
- 452.75
- 60558.79
- Narayana Hrudayalaya
- 2032.9
- -37.9
- -1.83
- 2145
- 1171.35
- 41581.76
- Global Health
- 1149.15
- 17.25
- 1.52
- 1323.85
- 936.05
- 30834.66
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 106.94
- 12.84
- 11.25
- 15.91
- Apollo Hospitals Enterprise
- 70.03
- 12.33
- 15
- 5.46
- Fortis Healthcare
- 69.55
- 6.6
- 6.88
- 9.18
- Narayana Hrudayalaya
- 52.51
- 11.53
- 25.11
- 11.8
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
Fortis Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 09-Oct-24
- Others
- 30-Aug-24
- To consider Fund Raising
- 06-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 22-Mar-25
- 19-Feb-25
- POM
- 07-Oct-24
- 05-Sept-24
- POM
- 02-Aug-24
- 11-Jul-24
- AGM
- 01-Apr-24
- 29-Feb-24
- POM
- 03-Jan-24
- 04-Dec-23
- POM
- 08-Dec-23
- 07-Nov-23
- POM
- 09-Sept-23
- 09-Aug-23
- POM
- 01-Aug-23
- 23-May-23
- AGM
- 01-Jul-23
- 02-Jun-23
- POM
- 01-Aug-22
- 21-Jun-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 20-May-25
- -
- -
- 1
- 23-May-24
- 24-Jul-24
- 24-Jul-24
- 1
- 24-May-23
- 20-Jul-23
- 20-Jul-23
- 1


